Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M916Revenue (TTM) $M7.2Net Margin (%)-2,276.9Altman Z-Score-8.5
Enterprise Value $M821EPS (TTM) $-1.3Operating Margin %-2,278.7Piotroski F-Score4
P/E(ttm)--Beneish M-Score-5.2Pre-tax Margin (%)-2,276.9Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %-9.6Quick Ratio7.4Cash flow > EarningsY
Price/Sales1265-y EBITDA Growth Rate %-1.4Current Ratio7.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-114.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-586.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M132ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJoel Greenblatt 2016-09-30 Sold Out $4.49 - $6.04
($5.36)
$ 6.7826%Sold Out0
ZIOPJoel Greenblatt 2016-06-30 Reduce-0.01%$5.31 - $8.92
($7.26)
$ 6.78-7%Reduce -55.68%42,723
ZIOPJoel Greenblatt 2016-03-31 Reduce$4.89 - $9.59
($6.81)
$ 6.78-0%Reduce -12.49%96,406
ZIOPJoel Greenblatt 2015-12-31 Buy 0.01%$8.07 - $14.57
($11.04)
$ 6.78-39%New holding110,163
ZIOPJoel Greenblatt 2015-06-30 Sold Out -0.01%$8.81 - $12.5
($10.36)
$ 6.78-35%Sold Out0
ZIOPJoel Greenblatt 2015-03-31 Buy 0.01%$4.96 - $14
($9.88)
$ 6.78-31%New holding109,080
ZIOPFirst Eagle Investment 2013-06-30 Sold Out -0.0012%$1.52 - $2.62
($1.86)
$ 6.78265%Sold Out0
ZIOPFirst Eagle Investment 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 6.7853%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BELBEL CAESAR JCOO, CLO, and Secretary 2015-11-19Sell153,333$12.84-47.2view
LEBEL FRANCOISExecutive Vice President R&D 2015-06-09Sell50,000$10.12-33view
BRENNAN MURRAYDirector 2015-06-04Sell40,000$9.7-30.1view
Lafond Kevin GVice Pres., Treasurer, & CAO 2015-06-03Sell57,500$9.65-29.74view
KIRK RANDAL JDirector, 10% Owner 2015-02-09Buy1,440,000$8.75-22.51view
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.593.71view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.230.38view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.9935.87view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.9237.8view
Fowler WycheDirector 2011-08-10Buy5,000$5.1930.64view

Quarterly/Annual Reports about ZIOP:

News about ZIOP:

Articles On GuruFocus.com
Intrexon Corp is expanding his business Jun 25 2015 
Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 

More From Other Websites
Hedge Funds Continue to Hold On To Quality Systems, Inc. (QSII) Dec 05 2016
ETFs with exposure to ZIOPHARM Oncology, Inc. : December 5, 2016 Dec 05 2016
5 Stocks Hedge Funds Hate The Most Nov 26 2016
ETFs with exposure to ZIOPHARM Oncology, Inc. : November 23, 2016 Nov 23 2016
Put sellers see floor in Ziopharm Nov 21 2016
ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 Nov 18 2016
ZIOPHARM ONCOLOGY INC Financials Nov 17 2016
ZIOPHARM Announces Clinical Data On Brain Cancer Drug Nov 17 2016
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial... Nov 17 2016
ZIOPHARM Announces Clinical Data on Ad-RTS-hIL-12 Demonstrates Survival Benefits in Patients with... Nov 17 2016
Sleeping Beauty System Used to Co-express CAR with Membrane-Bound IL-15 to Enhance Persistence of... Nov 15 2016
Ziopharm 3Q Loss $11M or 11 Cents a Share (ZIOP) Nov 10 2016
ZIOPHARM to Present at the Jefferies 2016 London Healthcare Conference Nov 10 2016
ZIOPHARM to Present at the Jefferies 2016 London Healthcare Conference Nov 10 2016
Ziopharm reports 3Q loss Nov 09 2016
Ziopharm reports 3Q loss Nov 09 2016
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 09 2016
ZIOPHARM Reports Third Quarter 2016 Financial Results and Provides Update on Recent Activities Nov 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)